PL EN


Preferences help
enabled [disable] Abstract
Number of results
2010 | 64 | 1-2 | 91-93
Article title

Seizures after desipramine in nine years old girl with ADHD syndrome

Content
Title variants
PL
Drgawki po zastosowaniu dezipraminy u dziewięcioletniej dziewczynki z zespołem ADHD
Languages of publication
EN
Abstracts
EN
The case of seizures in nine year old girl treated with desipramine (40 mg daily) for half year because of ADHD syndrome was presented.
PL
Przedstawiono opis drgawek u dziewięcioletniej dziewczynki z zespołem ADHD otrzymującej dezipraminę (40 mg na dobę) przez pół roku.
Keywords
Discipline
Year
Volume
64
Issue
1-2
Pages
91-93
Physical description
References
  • 1. Feeney D.J., Klykylo W.M. Medicationinduced seizures. J. Am. Acad. Child Adolesc. Psychiatry 1997; 36: 1018-1019.
  • 2. Preskorn S.H., Fast G.A. Tricyclic antidepressant- induced seizures and plasma drug concentration. J. Clin. Psychiatry 1992; 53: 160-162.
  • 3. Weding G.P., Oderda G.M., Klein- Schwartz W., German R.L. Relative toxicity of cyclic antidepressants. Ann. Emerg. Med. 1986; 15: 797-804.
  • 4. Zorc JJ. A 12 year-old girl with altered mental status and seizures. Pediatr Emerg Care 2004; 20: 613-616.
  • 5. Mahr G.C., Berchou R., Balon R. A grand mal seizure associated with desipramine and haloperidol. Can. J. Psychiatry 1987; 32: 463-464.
  • 6. Pataki C.S., Carlson G.A., Kelly K.L., Rapport M.D., Biancaniello T.M. Side effects of methylphenidate and desipramine alone and in combination in children. J. Am. Acad. Child Adolesc. Psychiatry 1993; 32:1065-1072.
  • 7. Sawyer W.T., Caudill J.L., Ellison M.J. A case of severe acute desipramine overdose. Am. J. Psychiatry 1984; 141:122-123.
  • 8. Montgomery S.A. Antidepressants and seizures: emphasis on newer agents and clinical implications. Int. J. Clin. Pract. 2005; 59:1435-1440
  • 9. Elia J., Ambrosini P.J., Rapoport J.L. Treatment of attention-defi cit-hyperactivity disorder. New Engl. J. Med. 1999; 340: 780-788.
  • 10. Zametkin A.J., Ernst M. Problems in the management of attention-defi cit-hyperactivity disorder. New Engl. J. Med. 1999; 34: 40-46.
  • 11. Amara S.G., Kuhar M.J. Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 1993; 16: 73-93.
  • 12. Cook E.H.Jr, Stain M.A., Krasowski M.D., Cox N.J., Olkon D.M., Kieff er J.E., Leventhal B.L. Association of attentiondefi cit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 1995; 56: 993-998.
  • 13. Aspide R., Gioroni-Carneval U.A., Sergent J.A., Sadile A.G. Non-selective attention and nitric oxide in putative animal model of attention-defi cit hyperactivity disorder. Behav. Brain Res. 1998; 95: 123- 133.
  • 14. Hendley E.D., Wessel D.J., Van Houtten J. Inbreeding of Wista-Kyoto rat strain with hyperactivity but without hypertension. Behav. Neural Biol. 1986; 45: 1-16.
  • 15. Cerbrone A., Pellicano M.P., Sadile A.G. Evidence for and against the Naples Highand Low-Excitability rats as genetic model to study hippocampal functions. Neurosci. Biobehav. Rev. 1993; 17: 295-304.
  • 16. Sagvolden T., Pettersen M.B., Lavsen M.C. Spontanously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat streins. Physiol. Behav. 1993; 54: 1047-1055.
  • 17. Kostrzewa R.M., Brus R, Kalbfl eish JH, Perry K.W., Fuller RW. Proposed animal model of attention defi cit hyperactivity disorder. Brain Res. Bull. 1994; 34: 161- 167.
  • 18. Brus R., Nowak P., Szkilnik R., Mikołajun U., Kostrzewa R.M. Serotoningergic attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity. Neurotox. Res. 2004; 6: 317-326.
  • 19. Arai S., Morita K., Kitayama S., Kumagai K., Kumagai M., Kihira K., Dohi T. Chronic inhibition of the norepinephrine transporter in the brain participates in seizure sensitization to cocaine and local anesthetics. Brain Res. 2003; 964: 83-90.
  • 20. Kleinrok Z., Gustaw J., Czuczwar S.J. Infl uence of antidepressant drugs on seizure susceptibility and the anticonvulsant activity of valproate in mice. J. Neural Transm. [Suppl] 1991; 34: 85-90.
  • 21. Cliff ord D.B., Rutherford J.L., Hicks F.G., Zorumski C.F. Acute eff ects of antidepressants on hippocampal seizures. Ann. Neural. 1985; 18: 629-697.
  • 22. Peterson S.L., Trzeciakowski J.P., Mary J.S. Chronic but not acute treatment with antidepressants enhances the electroconvulsive seizure response in rats. Neuropharmacol. 1985; 24: 941-946.
  • 23. Ahern T.H., Javors M.A., Eagles D.A., Martillotti J., Mitchell H.A., Liles L.C., Weinshenker D. The eff ect of chronic norepinephrine transporter inactivation of seizures susceptibility in mice. Neuropsychopharmacol. 2006; 31: 730-738.
  • 24. Kitayama T., Song L., Morita K., Morioka N., Dohi T. Down-regulation of norepinephrine transporter function induced by chronic administration of desipramine linking to the alteration of sensitivity of local- anaesthetics-induced convulsions and the counteraction by co-administration with local anaesthetics. Brain Res. 2006; 1096: 97-103.
  • 25. Warter J.M., Tranchant C., Marsecaux C., Depaulis A., Lannes B., Vergnes M. Immediate eff ects of 14 non MAOI antidepressants in rats with spontaneous petit mal-like seizures. Biol. Psychiat. 1990;14: 261-270.
  • 26. Kobayashi T., Washiyama K., Ikeda K. Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Various Antidepressant Drugs. Neuropsychopharmacology 2004; 29: 1841-1851.
  • 27. Luchins D.J., Oliver A.P., Wyatt R.J. Seizures with Antidepressants: An In Vitro Technique to Assess Relative Risk. Epilepsia 1984; 25: 25-32.
  • 28. Malatyńska E., Knapp R.J., Kieda M., Yamamura H.I. Antidepressants and seizure- interactions at the GABA-Receptor chloride-ionophore complex. Life Scienes 1988; 43: 303-307.
  • 29. Pineda M.R., Russell S.C. The use of a tricyclic antidepressant in epilepsy. Dis. Nerv. Syst. 1974; 35: 322-333.
  • 30. Baulac S., Gourfi nkel-An I., Nabbout R., Huberfeld G., Serratosa J., Leguern E., Baulac M. Fever, genes, and epilepsy. Lancet Neurol. 2004; 3: 421-430.
Document Type
article
Publication order reference
YADDA identifier
bwmeta1.element.psjd-30f46f88-1bab-40c3-9063-8d62e74e4daf
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.